UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Molecular pharmaceutics, ISSN 1543-8384, 07/2020, Volume 17, Issue 7, pp. 2299 - 2309
Journal Article
Molecular pharmaceutics, 01/2021
Journal Article
Pharmaceutical research, ISSN 0724-8741, 10/2018, Volume 35, Issue 10, pp. 1 - 8
Biochemistry, general | Biomedical Engineering | Biomedicine | Absorption | Food effect | Pharmacy | Effulx transporters | Medical Law | Nonlinear pharmacokinetics | Pharmacology/Toxicology | Inhibitor of apoptosis protein | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Femur | Femoral artery | Liver | Oral administration | Rats | Pharmacology | Glycoproteins | Bioavailability | Blood levels | Proteins | Inhibitors | Intestine | Rodents | Portal vein | Intestinal absorption | Pharmacokinetics | P-Glycoprotein | Food | Apoptosis | Index Medicus
Journal Article
European journal of pharmaceutical sciences, ISSN 0928-0987, 01/2020, Volume 142, pp. 105119 - 105119
Journal Article
Xenobiotica, ISSN 0049-8254, 4/2015, Volume 45, Issue 4, pp. 345 - 352
heteroactivation | drug-drug interactions (DDIs) | midazolam | substrate specificity | species differences | CYP3A4 | efavirenz | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Nifedipine - pharmacokinetics | Recombinant Proteins - metabolism | Hydroxylation | Species Specificity | Administration, Oral | Nifedipine - blood | Humans | Microsomes, Liver - metabolism | Rats | Substrate Specificity | Male | Testosterone - pharmacokinetics | Midazolam - pharmacokinetics | Rats, Sprague-Dawley | Haplorhini | Midazolam - analogs & derivatives | Animals | Drug Interactions | Midazolam - blood | Benzoxazines - pharmacokinetics | Cytochrome P-450 CYP3A - metabolism | Microsomes, Liver - drug effects | Benzoxazines - blood | Testosterone - blood | Index Medicus
Journal Article
Journal of pharmaceutical sciences, ISSN 0022-3549, 09/2017, Volume 106, Issue 9, pp. 2839 - 2846
inhibition | metabolism | drug interactions | cytochrome P450 | protein binding | microsomes | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Chemistry, Medicinal | Chemistry, Multidisciplinary | Science & Technology | Diltiazem - pharmacology | Antihypertensive Agents - pharmacology | Drug Interactions | Cytochrome P-450 CYP3A Inhibitors - pharmacology | Cytochrome P-450 CYP3A - metabolism | Models, Biological | United States | Humans | Microsomes, Liver - metabolism | Drug Discovery - methods | United States Food and Drug Administration | Index Medicus
Journal Article
Internal medicine (Tokyo, 1992), ISSN 0918-2918, 01/2020, Volume 59, Issue 4, pp. 551 - 556
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antigens | Autoantibodies | Insulinoma | Diabetes mellitus (insulin dependent) | Glucose | Insulin | Stomach cancer | Beta cells | Immune checkpoint | Ketoacidosis | Insulin resistance | Diabetes | Diabetes mellitus (non-insulin dependent) | Gastric cancer | Index Medicus | nivolumab | gastric cancer | C-peptide | thyroid peroxidase autoantibody | diabetes mellitus | insulinoma-associated antigen-2 autoantibody | Case Report
Journal Article
Journal of pediatric surgery case reports, ISSN 2213-5766, 06/2020, Volume 57, p. 101459
Journal Article
Pharmaceutical research, ISSN 0724-8741, 5/2019, Volume 36, Issue 5, pp. 1 - 14
Biochemistry, general | Biomedicine | intranasal administration | Pharmacy | membrane permeability | Medical Law | drug delivery | Pharmacology/Toxicology | Biomedical Engineering and Bioengineering | central nervous system | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Macaca fascicularis | Membranes, Artificial | Rats | Male | Olfactory Bulb - metabolism | Permeability | Administration, Intranasal | Rats, Sprague-Dawley | Blood-Brain Barrier - metabolism | Brain - metabolism | Animals | Pharmaceutical Preparations - administration & dosage | Pharmacokinetics | Drug Delivery Systems - methods | Drugs | Ropinirole | Drug delivery systems | Liability (Law) | Central nervous system | Primates | Methotrexate | Furosemide | Vehicles | Efflux | Intravenous administration | Cimetidine | Intranasal administration | Monkeys | Drug delivery | Atenolol | Monkeys & apes | Sulpiride | Substrates | Liability | Blood-brain barrier | Rodents | Nose | Ranitidine | Metformin | Midazolam | Didanosine | Index Medicus
Journal Article
10.
Full Text
TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window
Neuropsychopharmacology (New York, N.Y.), ISSN 0893-133X, 04/2019, Volume 44, Issue 5, pp. 961 - 970
Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Cell Line | Mice, Inbred C57BL | Rats, Long-Evans | Neural Stem Cells - drug effects | Excitatory Amino Acid Agents - adverse effects | Cognition - drug effects | Sulfonamides - pharmacology | Rats, Sprague-Dawley | Mice, Inbred ICR | Haplorhini | Seizures - chemically induced | Brain-Derived Neurotrophic Factor - drug effects | Animals | Excitatory Amino Acid Agents - pharmacology | Behavior, Animal - drug effects | Cell Proliferation - drug effects | Primary Cell Culture | Neurons - drug effects | Receptors, AMPA - drug effects | Excitatory Amino Acid Agents - administration & dosage | Seizing | Brain | Dioxides | Neurons | Propionic acid | Cognition | Monkeys | Drug development | Safety margins | Risk factors | Neurological diseases | Brain-derived neurotrophic factor | α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid | Sulfonamides | Rodents | Index Medicus | Depression | Pharmacology
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 01/2021, Volume 64, Issue 2, pp. 1103 - 1115
Journal Article
Xenobiotica, ISSN 0049-8254, 12/2019, Volume 49, Issue 12, pp. 1379 - 1387
long half-life | SCID mice | single-species scaling | plasma protein binding | Wajima superposition | PXB mice | Human PK prediction | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Animals | Hepatocytes | Liver - drug effects | Humans | Half-Life | Male | Mice, Transgenic | Mice, SCID | Pharmacokinetics | Chimera | Index Medicus
Journal Article
Xenobiotica, ISSN 0049-8254, 01/2021, Volume 51, Issue 1, pp. 51 - 60
chimeric humanized mouse | alpha-1 acid glycoprotein | TK-NOG mouse | unbound fraction | Albumin | plasma protein binding | PXB mouse | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Pharmaceutical Preparations - metabolism | Animals | Humans | Liver - metabolism | Mice | Hepatocytes - metabolism | Mice, SCID | Chimera | Disease Models, Animal | Protein Binding - physiology | Index Medicus
Journal Article